Mohamad Mohty Selected Research

Methotrexate (Mexate)

4/2024	Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
12/2023	The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT.
1/2022	Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
12/2020	Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation.
12/2019	How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
10/2006	Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamad Mohty Research Topics

Disease

201	Leukemia 05/2024 - 08/2003
199	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 08/2003
115	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 07/2003
68	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 07/2002
62	Multiple Myeloma 11/2023 - 03/2008
53	Neoplasms (Cancer) 01/2024 - 07/2002
40	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2003
23	Pathologic Complete Response 05/2024 - 05/2008
18	Bronchiolitis Obliterans Syndrome 10/2023 - 11/2002
17	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024 - 12/2012
17	Lymphoma (Lymphomas) 10/2022 - 05/2008
15	Residual Neoplasm 12/2023 - 02/2010
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2012
11	Primary Myelofibrosis (Myelosclerosis) 11/2021 - 02/2011
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 09/2008
10	Hematologic Diseases (Blood Diseases) 12/2023 - 02/2012
10	Infections 01/2021 - 11/2010
9	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 05/2023 - 10/2016
9	COVID-19 01/2023 - 01/2020
9	Disease Progression 10/2021 - 07/2011
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 12/2019
8	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 10/2010
8	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 02/2013
7	Philadelphia Chromosome 01/2023 - 03/2015
5	Fibrosis (Cirrhosis) 01/2022 - 01/2011
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 07/2011
4	Cytopenia 01/2024 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 01/2010
4	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2019
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2021 - 11/2012
4	Aplastic Anemia (Anemia, Hypoplastic) 10/2019 - 10/2013
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016 - 07/2002
4	Peripheral Nervous System Diseases (PNS Diseases) 03/2012 - 06/2008
3	Dysbiosis 11/2023 - 01/2021
3	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2016
3	Neutropenia 10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

74	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 10/2013
39	Busulfan (Busulfex)FDA Link 11/2023 - 07/2003
37	fludarabineIBA 02/2024 - 07/2003
36	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2024 - 07/2003
19	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2023 - 01/2016
16	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 10/2010
13	Melphalan (Alkeran)FDA LinkGeneric 12/2023 - 04/2015
12	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2019
12	Bortezomib (Velcade)FDA Link 01/2023 - 03/2008
10	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 01/2010
10	treosulfanIBA 02/2024 - 08/2012
10	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022 - 11/2010
8	Proteasome InhibitorsIBA 01/2023 - 06/2008
8	Lenalidomide (CC 5013)FDA Link 01/2022 - 02/2012
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024 - 03/2016
7	AntigensIBA 04/2024 - 02/2011
7	SteroidsIBA 08/2023 - 09/2009
7	defibrotideIBA 05/2023 - 10/2016
7	plerixafor FDA Link 03/2023 - 11/2012
7	Clofarabine (Clolar)FDA Link 01/2023 - 09/2012
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2015
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 11/2012
6	Methotrexate (Mexate)FDA LinkGeneric 04/2024 - 10/2006
6	thymoglobulin FDA Link 12/2023 - 12/2010
6	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 11/2008
6	Immunomodulating AgentsIBA 01/2023 - 12/2013
6	tisagenlecleucelIBA 10/2022 - 01/2019
6	Monoclonal AntibodiesIBA 01/2022 - 09/2009
6	fms-Like Tyrosine Kinase 3IBA 01/2022 - 08/2017
6	Thalidomide (Thalomid)FDA Link 10/2021 - 02/2010
6	Imatinib Mesylate (Gleevec)FDA Link 12/2015 - 06/2004
5	Calcineurin InhibitorsIBA 04/2024 - 03/2016
5	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 01/2018
5	carfilzomibIBA 01/2023 - 01/2019
5	Rituximab (Mabthera)FDA Link 09/2020 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2008
4	axicabtagene ciloleucelIBA 10/2022 - 12/2019
4	daratumumabIBA 01/2022 - 11/2019
4	VaccinesIBA 12/2021 - 07/2002
4	eculizumab FDA Link 01/2021 - 11/2012
4	Gemtuzumab (Mylotarg)FDA Link 12/2020 - 11/2008
4	CytokinesIBA 11/2020 - 12/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 10/2006
4	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 12/2012
4	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 08/2017
3	Core Binding Factors (Core-Binding Factor)IBA 04/2024 - 01/2020
3	AntibodiesIBA 01/2024 - 01/2020
3	Immunosuppressive Agents (Immunosuppressants)IBA 11/2023 - 12/2019
3	isatuximabIBA 01/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2016

Therapy/Procedure

209	Transplantation 05/2024 - 11/2002
183	Stem Cell Transplantation 05/2024 - 11/2002
116	Hematopoietic Stem Cell Transplantation 03/2024 - 05/2008
106	Cell Transplantation 04/2024 - 10/2011
87	Therapeutics 01/2024 - 09/2005
45	Drug Therapy (Chemotherapy) 03/2024 - 08/2003
25	Haploidentical Transplantation 05/2024 - 04/2015
22	Homologous Transplantation 04/2024 - 07/2003
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 04/2012
10	Autologous Transplantation 01/2023 - 11/2008
10	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 12/2022 - 11/2004
9	Immunotherapy 01/2022 - 07/2002
7	Salvage Therapy 01/2019 - 10/2006
3	Fecal Microbiota Transplantation 12/2023 - 01/2019